Navigation Links
Breast cancers behave differently before and after the age of 70
Date:4/18/2008

Berlin, Germany: Researchers in Belgium have discovered that increasing age affects the way breast cancer behaves. As women approach the age of 70, they become less likely to be diagnosed with aggressive tumours that have spread to the lymph nodes. But after 70, the cancer is increasingly likely to spread, particularly if the tumours are small.

Until now, there has been conflicting evidence on aging and lymph node involvement and this study is the first to show clearly how the link between the two changes before and after the age of 70.

Professor Hans Wildiers told the 6th European Breast Cancer Conference (EBCC-6) in Berlin today (Friday), that he suspects that women older than 70 have decreased immune defence mechanisms, which are less able to deal with tumours that are likely to metastasise to other sites in the body.

The effect of age of lymph node positivity is not straightforward. There seems to be a different effect between women aged up to 70 years and women older than 70. For the younger group of women, age appears to have a negative effect on lymph node status the older they become, the less likely the cancer is to have spread to the lymph nodes. For the older group of women (aged over 70), age appears to influence lymph node status in the opposite way the older they become, the more likely they are to have cancer cells in the lymph nodes if the tumour is small, said Prof Wildiers, who is adjunct head of clinic in the department of general medical oncology at the Multidisciplinary Breast Centre, University Hospitals Leuven, Belgium.

There is an interaction between age and tumour size, suggesting that, up to the age of 70, age mainly has a positive effect on lymph node status for older women with small tumours. A likely explanation is that breast tumours metastasise less frequently to lymph nodes with increasing age due to the decreased biological aggressiveness in these tumours. On the other hand, over the age of
'/>"/>

Contact: Emma Mason
wordmason@mac.com
ECCO-the European CanCer Organisation
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Herceptin and chemo improves response rates without major adverse effects in HER2 breast cancer
2. New type of drug shrinks primary breast cancer tumors significantly in just 6 weeks
3. New chemotherapy combo produces side effects, but no extra efficacy, in early breast cancer patients
4. Standard chemo works better against metastatic BRCA1/2 breast cancer than against sporadic tumors
5. Pregnant patients lose out in breast cancer treatment; a new approach is needed
6. Improving care and knowledge in translational research to fight breast cancer
7. Evidence now suggests eating soy foods in puberty protects against breast cancer
8. T-cadherin affects blood vessel growth in breast cancer, hormone from fat cells may play a role
9. MU researcher links hormone replacement therapy to breast cancer
10. Gene variant increases breast cancer risk
11. High levels of estrogen associated with breast cancer recurrence

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...rs recently received funding from the National Sci...ial to understanding the environment. The three gr...sistant professor in the Department of Biological ...te research projects. , His first project, title...nctions from the Leaf to the Landscape," will exam...
(Date:11/24/2009)...may help gut bacteria bind to the gastrointestinal...ducers to identify strains that are likely to be o...nteract with cells lining the gut to have a benefi... gut they are more likely to stick around long eno...e from the Institute of Food Research. IFR is an ...
(Date:11/24/2009)...ets of the earth,s history locked in its icy depth...information on the environments that have been sea...w, a team of researchers from nine institutions i...million dollars by the National Science Foundation...y. These scientists will drill through the West An...
Breaking Biology News(10 mins):Kent State University professors focus research on the environment with grants totaling $890,000 2A sticky solution for identifying effective probiotics 2LSU gets to the bottom of things -- in Antarctica 2A second skin 10768 1Petascale computational tools could revolutionize understanding of genomic evolution 10766 1Petascale computational tools could revolutionize understanding of genomic evolution 10766 2Driven by Customer Feedback BodyMedia Inc Announces Major Enhancements and Brand Change for GoWear Fit 61535 1Driven by Customer Feedback BodyMedia Inc Announces Major Enhancements and Brand Change for GoWear Fit 61535 2Driven by Customer Feedback BodyMedia Inc Announces Major Enhancements and Brand Change for GoWear Fit 61535 3Driven by Customer Feedback BodyMedia Inc Announces Major Enhancements and Brand Change for GoWear Fit 61535 4
...roduction line, with conveyer belts carrying the d...en to be cooked. , Now imagine what would happen...d oozed as a blob onto the conveyor, misshapen, an...rmed, unbaked pretzels. The result: a mess. And if...en, the backup of messy dough in the system would ...
... New York Academy of Sciences, 7 World Trade Cente...10007 , The Malaria Research Institute at the Joh...he New York Academy of Sciences present Progress A...f-day symposium to highlight the latest research d...eeting will include discussions of new diagnostic ...
... struggle first observed in a species of North Ame...tive, the European common lizard. The two species ... of evolution, yet they share behavioral and repro...the males, according to new research published in ...available online. , The triangle of competing st...
Other Biology News:Botched production of insulin molecule may lead to diabetes 2Botched production of insulin molecule may lead to diabetes 3Botched production of insulin molecule may lead to diabetes 4Progress Against Malaria: Developments on the Horizon 2Three-way mating game of North American lizard found in distant European relative 2Three-way mating game of North American lizard found in distant European relative 3Three-way mating game of North American lizard found in distant European relative 4
(Date:11/24/2009)...to also Visit Detroit , (... French Ambassador for International Investment, a..., , , , ,What: Ambassador Appia is available to m...iatives adopted by France to further develop the f...tion and development., , ,When: Available for Inte...
(Date:11/24/2009)...K, Iceland, November 24 ...ced that it has received notice from,the Nasdaq St...ock will be,suspended as of November 30, 2009 and ...d Exchange Commission, which will remove deCODE,s ...mpany files an appeal to the Nasdaq,Listing Qualif...
(Date:11/24/2009).../PRNewswire-Asia/ -- NOD Pharmaceuticals Inc. anno...as allowed the patent application for,its nano-par...NOD technology is a highly efficient approach to i...nano-particles to enable oral delivery of drugs,ot... is a platform technology,that can be applied to m...
(Date:11/24/2009)...ently approved the Promega PowerPlex 16 HS System ...ting DNA records for the National DNA Index System...B) -- The FBI recently approved the Promega Power...rticipating in, or generating DNA records for, the...contains more than seven million profiles and has ...
Breaking Biology Technology:deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2
...UVER, May 30 /PRNewswire-FirstCall/ - OncoGenex Ph...ced preliminary results of a Phase 1 trial present...iety of Clinical Oncology (ASCO) Annual Meeting. P...X-427 was well tolerated as a monotherapy. In addi... tumor cells at all doses evaluated as well as evi...
... Several of LASIK and refractive eye surgery exp...hose eye doctors honored at the recent American So...nnual meeting in San Francisco, California. Dr. P... Trattler were on the winning team for the annual ...tition between two teams of refractive surgery exp...
... Martek Biosciences Corporation (Nasdaq: MATK ) ...8th Annual Needham Life Sciences Conference which ... New York Palace Hotel in New York City. Peter L....esent on Thursday, June 11, 2009, at 2:30 p.m. Eas...resentation can be accessed at: http://www.wsw...
Other Biology Technology:OncoGenex Pharmaceuticals Announces OGX-427 Treatment Demonstrates Safety, Evidence of Declines in Circulating Tumor Cells and Reductions in Tumor Markers in a Phase 1 Cancer Trial 2OncoGenex Pharmaceuticals Announces OGX-427 Treatment Demonstrates Safety, Evidence of Declines in Circulating Tumor Cells and Reductions in Tumor Markers in a Phase 1 Cancer Trial 3OncoGenex Pharmaceuticals Announces OGX-427 Treatment Demonstrates Safety, Evidence of Declines in Circulating Tumor Cells and Reductions in Tumor Markers in a Phase 1 Cancer Trial 4OncoGenex Pharmaceuticals Announces OGX-427 Treatment Demonstrates Safety, Evidence of Declines in Circulating Tumor Cells and Reductions in Tumor Markers in a Phase 1 Cancer Trial 5LASIK and Vision Correction Experts from Trusted LASIK Surgeons Directory Achieve Top Awards at ASCRS Meeting 2LASIK and Vision Correction Experts from Trusted LASIK Surgeons Directory Achieve Top Awards at ASCRS Meeting 3LASIK and Vision Correction Experts from Trusted LASIK Surgeons Directory Achieve Top Awards at ASCRS Meeting 4LASIK and Vision Correction Experts from Trusted LASIK Surgeons Directory Achieve Top Awards at ASCRS Meeting 5LASIK and Vision Correction Experts from Trusted LASIK Surgeons Directory Achieve Top Awards at ASCRS Meeting 6LASIK and Vision Correction Experts from Trusted LASIK Surgeons Directory Achieve Top Awards at ASCRS Meeting 7
Silencer Pre-designed siRNA, standard purity from Ambion
Silencer Validated siRNA - with sequence information 20 nmol from Ambion
Silencer Validated siRNA - with sequence information 20 nmol from Ambion
Silencer Validated siRNA - with sequence information 5 nmol from Ambion
Biology Products: